Register Login
Register to leave comments
  • News bot March 10, 2026, 11:59 a.m.

    📋 ADC THERAPEUTICS SA (ADCT) - Financial Results

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 07:58:12

    Event Type: Financial Results

    Event Details:

    ADC THERAPEUTICS SA (ADCT) Reports the reporting period Financial Results ADC THERAPEUTICS SA (ADCT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (1,699)
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 261338
      • anticipated by year-end 2026
      • anticipated in 2Q 2026
      • expected in second quarter 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expense Loss From Operations -32.44K -121.50K $89.06K +73.30%
    Other Income Expense Interest Income 2.63K 8.81K $-6.18K -70.11%
    Other Income Expense Interest Expense -11.92K -51.63K $39.71K +76.92%
    Equity In Net Losses Of Joint Venture Net Loss -30.73K -30.73K $0.00 +0.00%
    Net Loss Per Share Net Loss Per Share -0.29 -0.29 $0.00 +0.00%
    Noncurrent Assets Operating Lease Right Of Use Assets 1.30K 8.35K $-7.06K -84.47%
    Current Liabilities Accounts Payable 9.18K 9.18K $0.00 +0.00%
    Other Long Term Liabilities 2.81K 2.43K $377.00 +15.50%
    Net Loss -30.73K -30.73K $0.00 +0.00%
    Net Loss Per Share -0.25 -0.25 $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ADC THERAPEUTICS SA
    • Ticker Symbol: ADCT

Search

News categories